heptane-1,7-bis(dimethyl-3'-phthalimidopropylammonium) has been researched along with nicotine in 1 studies
| Studies (heptane-1,7-bis(dimethyl-3'-phthalimidopropylammonium)) | Trials (heptane-1,7-bis(dimethyl-3'-phthalimidopropylammonium)) | Recent Studies (post-2010) (heptane-1,7-bis(dimethyl-3'-phthalimidopropylammonium)) | Studies (nicotine) | Trials (nicotine) | Recent Studies (post-2010) (nicotine) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 28,519 | 2,280 | 9,302 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christopoulos, A; Loiacono, R; Mitchelson, F | 1 |
1 other study(ies) available for heptane-1,7-bis(dimethyl-3'-phthalimidopropylammonium) and nicotine
| Article | Year |
|---|---|
Binding of the muscarine receptor antagonist heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide at cholinoceptor sites.
Topics: Animals; Binding, Competitive; Bis-Trimethylammonium Compounds; Cerebral Cortex; Female; In Vitro Techniques; Isoindoles; Kinetics; Lung; Male; Muscarinic Antagonists; Myocardium; Nicotine; Parasympatholytics; Pirenzepine; Quinuclidinyl Benzilate; Rats; Rats, Wistar; Receptors, Cholinergic | 1993 |